Humana Changes in securities lending payable decreased by 169.6% to -$55.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 131.4%, from $175.00M to -$55.00M.
Fluctuations reflect changes in the volume of securities lending activity and the firm's approach to managing short-term liquidity.
The net change in liabilities arising from securities lending transactions where the company receives cash collateral. T...
Common in financial services and insurance firms with large investment portfolios; varies based on market activity.
financing_increase_decrease_in_securities_lending_payable| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $79.00M | $282.00M | $57.00M | $175.00M | $93.00M | $79.00M | -$55.00M |
| QoQ Change | — | — | — | — | — | — | — | — | — | — | +257.0% | -79.8% | +207.0% | -46.9% | -15.1% | -169.6% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | — | -67.0% | +38.6% | -131.4% |